Cargando…

Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer

PURPOSE OF REVIEW: This review aims to explore the current state of research on the use of artificial intelligence (AI) in the management of prostate cancer. We examine the various applications of AI in prostate cancer, including image analysis, prediction of treatment outcomes, and patient stratifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Timothy N., Wong, Elyssa Y., Ma, Runzhuo, Yang, Cherine H., Dalieh, Istabraq S., Hung, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090000/
https://www.ncbi.nlm.nih.gov/pubmed/36808595
http://dx.doi.org/10.1007/s11934-023-01149-6
_version_ 1785022872373166080
author Chu, Timothy N.
Wong, Elyssa Y.
Ma, Runzhuo
Yang, Cherine H.
Dalieh, Istabraq S.
Hung, Andrew J.
author_facet Chu, Timothy N.
Wong, Elyssa Y.
Ma, Runzhuo
Yang, Cherine H.
Dalieh, Istabraq S.
Hung, Andrew J.
author_sort Chu, Timothy N.
collection PubMed
description PURPOSE OF REVIEW: This review aims to explore the current state of research on the use of artificial intelligence (AI) in the management of prostate cancer. We examine the various applications of AI in prostate cancer, including image analysis, prediction of treatment outcomes, and patient stratification. Additionally, the review will evaluate the current limitations and challenges faced in the implementation of AI in prostate cancer management. RECENT FINDINGS: Recent literature has focused particularly on the use of AI in radiomics, pathomics, the evaluation of surgical skills, and patient outcomes. SUMMARY: AI has the potential to revolutionize the future of prostate cancer management by improving diagnostic accuracy, treatment planning, and patient outcomes. Studies have shown improved accuracy and efficiency of AI models in the detection and treatment of prostate cancer, but further research is needed to understand its full potential as well as limitations.
format Online
Article
Text
id pubmed-10090000
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100900002023-04-13 Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer Chu, Timothy N. Wong, Elyssa Y. Ma, Runzhuo Yang, Cherine H. Dalieh, Istabraq S. Hung, Andrew J. Curr Urol Rep Prostate Cancer (S Prasad, Section Editor) PURPOSE OF REVIEW: This review aims to explore the current state of research on the use of artificial intelligence (AI) in the management of prostate cancer. We examine the various applications of AI in prostate cancer, including image analysis, prediction of treatment outcomes, and patient stratification. Additionally, the review will evaluate the current limitations and challenges faced in the implementation of AI in prostate cancer management. RECENT FINDINGS: Recent literature has focused particularly on the use of AI in radiomics, pathomics, the evaluation of surgical skills, and patient outcomes. SUMMARY: AI has the potential to revolutionize the future of prostate cancer management by improving diagnostic accuracy, treatment planning, and patient outcomes. Studies have shown improved accuracy and efficiency of AI models in the detection and treatment of prostate cancer, but further research is needed to understand its full potential as well as limitations. Springer US 2023-02-18 2023 /pmc/articles/PMC10090000/ /pubmed/36808595 http://dx.doi.org/10.1007/s11934-023-01149-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Prostate Cancer (S Prasad, Section Editor)
Chu, Timothy N.
Wong, Elyssa Y.
Ma, Runzhuo
Yang, Cherine H.
Dalieh, Istabraq S.
Hung, Andrew J.
Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer
title Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer
title_full Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer
title_fullStr Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer
title_full_unstemmed Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer
title_short Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer
title_sort exploring the use of artificial intelligence in the management of prostate cancer
topic Prostate Cancer (S Prasad, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090000/
https://www.ncbi.nlm.nih.gov/pubmed/36808595
http://dx.doi.org/10.1007/s11934-023-01149-6
work_keys_str_mv AT chutimothyn exploringtheuseofartificialintelligenceinthemanagementofprostatecancer
AT wongelyssay exploringtheuseofartificialintelligenceinthemanagementofprostatecancer
AT marunzhuo exploringtheuseofartificialintelligenceinthemanagementofprostatecancer
AT yangcherineh exploringtheuseofartificialintelligenceinthemanagementofprostatecancer
AT daliehistabraqs exploringtheuseofartificialintelligenceinthemanagementofprostatecancer
AT hungandrewj exploringtheuseofartificialintelligenceinthemanagementofprostatecancer